Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 8/20 | 0.56 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.51 |
| ▸ | NPY4R | P50391 | 4/20 | 0.51 |
| ▸ | NPY1R | P25929 | 3/20 | 0.51 |
| ▸ | FAAH | O00519 | 1/20 | 0.49 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.48 |
| ▸ | NPY2R | P49146 | 1/20 | 0.47 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | GLP1R | P43220 | 3/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29640346 | 1.00 | NOD1 (0.56) | NOD1NPY5RNPY4RNPY1RFAAH | |
| SCHEMBL30496970 | 1.00 | NOD1 (0.56) | NOD1NPY5RNPY4RNPY1RFAAH | |
| SCHEMBL29640329 | 1.00 | NOD1 (0.56) | NOD1NPY5RNPY4RNPY1RFAAH | |
| SCHEMBL539142 | 0.91 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2343614 | 0.91 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2344383 | 0.91 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL11102825 | 0.91 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL11102827 | 0.91 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2340732 | 0.91 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R | |
| SCHEMBL2341089 | 0.91 | NOD1 (0.66) | NOD1SLC6A5EPHX2GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116979-A1 | METHOD FOR PRODUCING LIPIDIC PEPTIDE | NISSAN CHEMICAL CORPORATION (JP) | 2024-04-11 | — | — | US | disclosed |
| US-20240067675-A1 | METHOD FOR PRODUCING LIPID PEPTIDE | NISSAN CHEMICAL CORPORATION (JP) | 2024-02-29 | — | — | US | disclosed |
| EP-4265629-A1 | METHOD FOR PRODUCING LIPID PEPTIDE | Nissan Chemical Corporation (JP) | 2023-10-25 | — | — | EP | disclosed |
| CN-116648455-A | Method for preparing lipid peptide | 日产化学株式会社 | 2023-08-25 | — | — | CN | disclosed |
| CN-116615435-A | Method for preparing lipid peptide | 日产化学株式会社 | 2023-08-18 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067675-A1 | METHOD FOR PRODUCING LIPID PEPTIDE | VIP, NGLY1, NPPA | NOD1 4121/4885NPY5R 1461/4885NPY4R 652/4885 |
| US-20240116979-A1 | METHOD FOR PRODUCING LIPIDIC PEPTIDE | NPPA, VIP, NGLY1 | NOD1 4139/4885NPY5R 655/4885NPY4R 461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.